• Items
  • Login
  • Register

Vaccine Manufacturing, Scaling, Supply Chain, and Administration Issues

Add to Cart
Back to Results
Recorded February 4, 2021 | On-Demand Webinar

Once a vaccine is ready for market, a company must adhere to continuing manufacturing, reporting, inspection, and other requirements. The sponsor company must also scale up production in preparation for widespread distribution and ensure that components and other materials used in the manufacturing process are readily available. Lastly, the vaccine must be distributed, stored, and administered to the population. This session will describe the different requirements at play, utilizing COVID-19 vaccine-related practical examples and considerations.

This session was recorded as part of FDLI’s virtual course, "Fundamentals of Vaccine Regulation: Scientific Ingenuity and Rigorous Review" in February 2021.

Assign Members : 
Members Assigned | Assign all contacts Unassign all contacts

  • All
  • Assigned
  • Unassigned
Add New Contact

Add New Contact





Cancel
Save

Assign Full Name Account Name Email Role
Total Records - Showing Page

Discounts and special pricing for additional items will be applied once you add the item to your cart.
Previous Next